Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
ONGLYZA (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
Bristol Myers-Squibb Company, 06/26/09
Bristol-Myers Squibb Company and AstraZeneca announced that their marketing authorization application for ONGLYZA received a positive opinion from the Committee for Medicinal Products for Human Use for the treatment of type 2 diabetes in adults as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09